Affiliation:
1. Pirogov Russian National Research Medical University
Abstract
A woman’s health during the perimenopausal transition is not irrelevant because of the risk zone in which this category of women falls. Mature patients often have complaints associated with the menopausal syndrome. The increase in life expectancy of women, their active lifestyle that they want to maintain, which is not always possible due to the presence of a number of adverse factors such as the environment, stress factors, the presence of chronic diseases that tend to frequent exacerbations, all this aggravates the overall condition of women and primarily has a negative impact on their psycho-emotional health. The menopausal syndrome, which can debut during the perimenopausal transition, further complicates the woman’s condition. The job of a specialist gynaecologist is to help and manage these patients. It would seem that there is no question: the clinical guidelines and protocols are clearly prescribed algorithms for the management and therapy of such patients, where it is stated in black and white about the prescription of menopausal hormone therapy, which is pathogenetic and justified in the development of the menopausal syndrome and the complaints associated with it. But the prescription of this therapy is associated with a set of risks and side effects. Non-hormonal therapy is a good alternative in the treatment of menopausal disorders, given that hormonal treatment is contraindicated in a number of women. This article presents a cross-section of the literature data on the results of prescribing a dietary supplement MENSE® (Aquion JSC, Russia) in women with psycho-emotional tension during menopause. MENSE® complex contains an impressive range of components (β-alanine, 5-hydroxytryptophan, phytoestrogens – soy isoflavones, B vitamins, folic acid, vitamins E and C) favorably affecting the female body and improves the quality of her life during perimenopause. This complex can be recommended for patients with menopausal syndrome as an effective therapeutic agent for the period of selection of menopausal hormonal therapy or the presence of contraindications to it. MENSE® is an effective complex for improving the quality of life of perimenopausal women against the background of psycho-emotional conditions.
Reference63 articles.
1. Harlow S.D., Gass M., Hall J.E., Lobo R., Maki P., Rebar R.W. et al. Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging. J Clin Endocrinol Metab. 2012;97(4):1159–1168. https://doi.org/10.1210/jc.2011-3362.
2. Balan V.E., Eliseeva N.A. Epidemiology of the climacteric syndrome. Akusherstvo i Ginekologiya (Russian Federation). 1995;71(3):5. (In Russ.)
3. Savelyeva G.M., Breusenko V.G., Kappusheva L.M. Postmenopause. Physiology and pathology. Vestnik Rossiyskoy Assotsiatsii Akusherstva i Ginekologii. 1998;(2):45–49. (In Russ.)
4. Antonova A.A., Bachilo E.V., Barylnik J.B. Modern approach to the problem of mental disorders in perimenopausal females (review). Saratov Journal of Medical Scientific Research. 2012;8(2):379–383. (In Russ.) Available at: https://ssmj.ru/system/files/archive/ssmj-2012-2-suppl1-full.pdf.
5. Barbarash N.A., Chichilenko M.V., Tarasenko N.P., Barbarash L.S. Extragenital features of the biology and physiology of the female body (review). Bulletin of Siberian Branch of Russian Academy of Medical Sciences. 2003;23(3):53–58. (In Russ.) Available at: https://elibrary.ru/item.asp?id=9126361.